Original title:&nbsp;Transcatheter Aortic Valve Implantation With the Edwards SAPIEN Versus the Medtronic CoreValve Revalving System Devices. A Multicenter Collaborative Study: The PRAGMATIC Plus Initiative (Pooled-RotterdAm-Milano-Toulouse In Collaboration).&nbsp;Reference:&nbsp;Alaide Chieffo et al. J Am Coll Cardiol 2013;61:830&ndash;6. Since the introduction of percutaneous aortic valve replacement (TAVR), two devices have been widely used. For one side, the self-expanding<a href="https://solaci.org/en/2013/03/10/corevalve-versus-edwards-equivalent-results-at-one-year/" title="Read more" >...</a>

Original title:&nbsp;Incidence, Management and Outcomes of Cardiac Tamponade During Transcatheter Aortic Valve Implantation&nbsp;Reference:&nbsp;Ahmed Rezq et al. J Am Coll Cardiol Intv 2012;5:1264 &ndash;72 Transcatheter Aortic Valve Implantation (TAVI) for high risk patients is a valid strategy today but not without complications. Among these is cardiac tamponade, still rare but important because of its implication.&nbsp; There<a href="https://solaci.org/en/2013/01/23/tavi-and-cardiac-tamponade-a-rare-but-serious-complication/" title="Read more" >...</a>

Original title:&nbsp;Impact of a New Conduction Defect Alter Transcatheter Aortic Valve Implantation on Left Ventricular Function&nbsp;Reference:&nbsp;Rainer Hoffmann, et al. J Am Coll Cardiol Intv 2012;5:1257&ndash; 63. TAVI development in high risk patients can produce new conduction defects and require a definitive pacemaker in almost a third of treated patients.&nbsp; The aim of this study was<a href="https://solaci.org/en/2013/01/21/post-tavi-lvef-improvement-only-with-no-new-conduction-defects/" title="Read more" >...</a>

Original title:&nbsp;Trends in outcome after transfemoral transcatheter aortic valve implantation. Pooled-RotterdAm-Milano-Toulouse In Collaboration Plus (PRAGMATICPlus) initiative.&nbsp;Reference:&nbsp;Nicolas M. Van Mieghem et al. Am Heart J 2012;0:1-10. Article in press. Since its introduction in 2002, Transfemoral Transcatheter Aortic Valve Implantation (TAVI) has turned into a viable and safe strategy to treat patients with severe acute stenosis and<a href="https://solaci.org/en/2013/01/15/transfemoral-transcatheter-aortic-valve-implantation-more-experience-and-better-results/" title="Read more" >...</a>

Original title: Valve-in-Valve Implantation of Medtronic CoreValve Prosthesis in Patients with Failing Bioprosthetic Aortic Valves. Reference: Axel Linke el al. Circ Cardiovasc Interv. 2012;5:689-697. This study evaluates the safety, feasibility and results of Core Valve implants on patients with bioprostheses dysfunctional by stenosis, insufficiency or a combination of both. Biological prostheses are preferred over mechanical ones for patients<a href="https://solaci.org/en/2012/11/02/the-largest-published-series-of-valve-in-valve-with-core-valve-medtronic/" title="Read more" >...</a>